Welcome to Ebnet Medical – for better care and positive economic impact
Vascular access for infusion therapy is life-saving, with billions of venous catheters being used per year in a growing market.
Numerous studies describe very high complication rates with tremendous additional costs for the healthcare and reimbursement systems.
Up to 69% of common (peripheral) venous catheters fail before the end of therapy.(1)
Premature removal of common venous catheters leads to conservatively estimated additional costs of 1.5 billion US dollars per year in the US alone.(2)
In up to 54% of children, the vein is not successfully accessed on the first attempt.(3)
The annual costs resulting from unintentional dislodgement of common venous catheters amount to over 266 million US dollars in the US alone.(4)
Moreover, common vascular catheters frequently kink, posing potentially life-threatening consequences such as circulatory arrest. The idea of tubes kinking would be considered unthinkable in numerous non-medical contexts.
We are developing safe and cost-effective products within proprietary platform technologies. Ebnet Medical holds the leading intellectual property portfolio for next-generation vascular access.
We truly understand the needs of patients and providers and focus on highly relevant opportunities.
